TIPS-3, PHRI’s study on the polypill, will be presented at a late-breaking science session at the American Heart Association’s (virtual) Scientific Sessions on November 13, 2020.
Part of the Late Breaking Science Session: Bending the Curve for CV Disease – Precision or PolyPill?, the TIPS-3 presentations will include:
- “A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of The International Polycap Study (TIPS)-3” by Prem Pais, St John’s Research Institute, Bangalore, India.
- “Aspirin Alone and in Combination with a Polypill in Cardiovascular Disease Primary Prevention: Results from The International Polycap Study (TIPS)-3” by Salim Yusuf, PHRI Executive Director.
Also on November 13, 2020, Dr. Yusuf will participate in a live “Meet the Trialists” session, discussing the TIPS-3 study.